TITLE:
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

CONDITION:
Zollinger-Ellison Syndrome

INTERVENTION:
Esomeprazole magnesium (Nexium)

SUMMARY:

      This research study will determine if esomeprazole, when administered twice daily at 40, 80,
      or 120 mg doses, can control excessive stomach acid secretion.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Males or females at least 18 years of age.

          -  Diagnosis of Zollinger-Ellison Syndrome or idiopathic hypersecretion

        Exclusion Criteria:

          -  Pregnant or lactating females

          -  History of drug addiction or alcohol abuse within 12 months prior to Screening.

          -  History of intolerance to any proton pump inhibitors or any ingredient in their
             formulation.
      
